Serum Galectin-3 and IL-6 as Inflammatory Markers in Bipolar Disorder: Insights from Manic and Euthymic Episodes
Journal of Clinical Medicine · 26.01.2025 · 14 (3) · 803
DOI: 10.3390/jcm14030803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.01.2025. Verfasst von Alev Lazoglu Ozkaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Erzurum City Hospital, 25240 Erzurum, Türkiye. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This study aimed to assess serum Galectin-3 (Gal-3) and IL-6 levels, along with other inflammatory markers, in type-1 bipolar disorder (BD) patients and explore their relationship with clinical features, metabolic parameters, and symptom severity.
Background
The study included 38 manic, 35 euthymic BD patients, and 40 healthy controls. Sociodemographic data, such as age, gender, alcohol and smoking habits, and body mass index (BMI), were recorded.
Methods
The Young Mania Rating Scale (YMRS) and Hamilton Depression Rating Scale (HAM-D) were administered to patients. Biochemical measurements included Gal-3, IL-6, CRP, neutrophil, lymphocyte, platelet counts, and inflammatory indices like NLR, PLR, SII, and SIRI.
Results
Gal-3 levels significantly differed among the groups (F = 52.251, p < 0.001), with the highest levels in euthymic patients. IL-6 levels were elevated in both manic and euthymic patients compared to controls (F = 7.379, p = 0.001). Manic patients had significantly higher levels of neutrophils, monocytes, CRP, NLR, PLR, SII, and SIRI. A positive correlation was found between Gal-3 levels, the total number of episodes, and YMRS scores in manic patients. In euthymic patients, Gal-3 levels correlated positively with disease duration and episode count.
Conclusions
Elevated Gal-3 levels, particularly in the euthymic phase, may serve as a biomarker for BD and indicate ongoing inflammation. These findings suggest Gal-3 could help identify BD and differentiate the euthymic phase.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Erzurum City Hospital, 25240 Erzurum, Türkiye.
- Department of Psychiatry, Erzurum Faculty of Medicine, University of Health Sciences, 25240 Erzurum, Türkiye.
- Department of Psychiatry, Elazig Mental Health and Diseases Hospital, 23100 Elazig, Türkiye.
- Department of Endocrinology and Metabolism, Faculty of Medicine, Recep Tayyip Erdogan University, 53100 Rize, Türkiye.
ORCID-Profile: Alev Lazoglu Ozkaya, Nilifer Gürbüzer, Elif Özcan Tozoğlu, Filiz Mercantepe
Zitieren
APA
Ozkaya, A. L., Gürbüzer, N., Tozoğlu, E. Ö., Akyildirim, S., & Mercantepe, F. (2025). Serum Galectin-3 and IL-6 as Inflammatory Markers in Bipolar Disorder: Insights from Manic and Euthymic Episodes. Journal of Clinical Medicine, 14(3), 803. https://doi.org/10.3390/jcm14030803
Vancouver
Ozkaya AL, Gürbüzer N, Tozoğlu EÖ, Akyildirim S, Mercantepe F. Serum Galectin-3 and IL-6 as Inflammatory Markers in Bipolar Disorder: Insights from Manic and Euthymic Episodes. Journal of Clinical Medicine. 2025;14(3):803. doi:10.3390/jcm14030803
BibTeX
@article{Ozkaya2025,
author = {Ozkaya, Alev Lazoglu and Gürbüzer, Nilifer and Tozoğlu, Elif Özcan and Akyildirim, Sumeyya and Mercantepe, Filiz},
title = {Serum Galectin-3 and IL-6 as Inflammatory Markers in Bipolar Disorder: Insights from Manic and Euthymic Episodes},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {3},
pages = {803},
doi = {10.3390/jcm14030803}
}
EUVIMED